Page 1 of Clinical Trials for adult grade III meningioma, 90 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Last Updated: April 6, 2011
Condition(s): Brain and Central Nervous System Tumors
2
Recruiting
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
Last Updated: February 6, 2009
Condition(s): Brain and Central Nervous System Tumors
3
Recruiting
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2
Last Updated: November 7, 2011
Condition(s): Anaplastic Astrocytoma; Anaplastic Ependymoma; Anaplastic Meningioma; Anaplastic Oligodendroglioma; Brain Stem Glioma; Ependymoblastoma; Giant Cell Glioblastoma; Glioblastoma; Gliosarcoma; Grade III Meningioma; Meningeal Hemangiopericytoma; Mixed Glioma; Pineal Gland Astrocytoma; Brain Tumor
4
Active, not recruiting
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
Last Updated: April 8, 2011
Condition(s): Brain and Central Nervous System Tumors; Sarcoma
5
Recruiting
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
Last Updated: April 10, 2012
Condition(s): Brain and Central Nervous System Tumors
6
Completed
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
Last Updated: October 31, 2011
Condition(s): Brain and Central Nervous System Tumors; Head and Neck Cancer; Radiation Toxicity; Sarcoma
7
Completed
Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Last Updated: July 31, 2010
Condition(s): Brain and Central Nervous System Tumors
8
Completed
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Last Updated: February 19, 2012
Condition(s): Cancer
9
Active, not recruiting
Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma
Last Updated: July 23, 2008
Condition(s): Brain and Central Nervous System Tumors
10
Recruiting
Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
Last Updated: July 28, 2010
Condition(s): Brain and Central Nervous System Tumors; Neurofibromatosis Type 1; Neurofibromatosis Type 2; Precancerous Condition
11
Completed
Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
Last Updated: May 15, 2010
Condition(s): Brain and Central Nervous System Tumors
12
Completed
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
Last Updated: May 18, 2012
Condition(s): Brain and Central Nervous System Tumors
13
Active, not recruiting
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
Last Updated: October 18, 2011
Condition(s): Brain and Central Nervous System Tumors; Lymphoma; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
14
Recruiting
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Last Updated: January 19, 2012
Condition(s): Brain and Central Nervous System Tumors; Metastatic Cancer
15
Recruiting
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Last Updated: April 7, 2011
Condition(s): Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Fatigue; Metastatic Cancer; Psychosocial Effects of Cancer and Its Treatment; Radiation Toxicity
16
Completed
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Last Updated: March 14, 2012
Condition(s): Cancer
17
Completed
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Last Updated: July 31, 2010
Condition(s): Brain and Central Nervous System Tumors
18
Active, not recruiting
Antineoplaston Therapy in Treating Patients With Meningioma
Last Updated: July 23, 2008
Condition(s): Brain and Central Nervous System Tumors
19
Completed
Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
Last Updated: April 13, 2010
Condition(s): Brain and Central Nervous System Tumors
20
Active, not recruiting
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Last Updated: May 2, 2011
Condition(s): Brain and Central Nervous System Tumors; Metastatic Cancer; Radiation Toxicity

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=adult+grade+III+meningioma

Page 1 of Clinical Trials for adult grade III meningioma, 90 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About